AI & ChatGPT searches , social queries for CONIVAPTAN
Search references for CONIVAPTAN. Phrases containing CONIVAPTAN
See searches and references containing CONIVAPTAN!
Search references for CONIVAPTAN. Phrases containing CONIVAPTAN
See searches and references containing CONIVAPTAN!CONIVAPTAN
Chemical compound
Conivaptan, sold under the brand name Vaprisol, is a non-peptide inhibitor of the receptor for anti-diuretic hormone, also called vasopressin. It was approved
Conivaptan
Class of drugs
receptor antagonists and include conivaptan, tolvaptan, demeclocycline, and mozavaptan (OPC-31260), as well as lithium. Conivaptan hydrochloride and tolvaptan
Aquaretic
Abnormal release of urination-reducing hormones in the body
protein intake. The vasopressin receptor 2 antagonists, tolvaptan or conivaptan, may also be used. The presence of cerebral edema, or other moderate to
Syndrome of inappropriate antidiuretic hormone secretion
Syndrome_of_inappropriate_antidiuretic_hormone_secretion
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Oxytocin_receptor_agonist
Agent that interferes with action at the vasopressin receptors
clinical use or in clinical trials as of 2009. Unselective (mixed V1A/V2) Conivaptan V1A selective (V1RA) Relcovaptan V1B selective (V3RA) Nelivaptan V2 selective
Vasopressin receptor antagonist
Vasopressin_receptor_antagonist
Mammalian hormone released from the pituitary gland
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasopressin
Failure of the heart to provide sufficient blood flow throughout the body
relative. Vasopressin receptor antagonists can also treat heart failure. Conivaptan is the first medication approved by the US Food and Drug Administration
Heart_failure
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
TC_OT_39
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Retosiban
Medication
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Desmopressin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Relcovaptan
Low sodium concentration in the blood
tentative evidence that vasopressin receptor antagonists (vaptans), such as conivaptan, may be slightly more effective than fluid restriction in those with high
Hyponatremia
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Demoxytocin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Selepressin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Lithium_carbonate
Japanese pharmaceutical company
pancreatic cancer – marketed with Hoffmann-La Roche (Genentech). Vaprisol (conivaptan) – Hyponatremia Veozah (fezolinetant) - Hot Flashes (vasomotor symptoms)
Astellas_Pharma
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
L-368,899
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
LIT-002
Chemical compound
(November 20, 2006). "Neue Wirkstoffe - Conivaptan". Österreichische Apothekerzeitung (in German) (24/2006). "Conivaptan hydrochloride". Molecule of the Month
Mozavaptan
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
TGOT
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Tolvaptan
Small-molecule oxytocin receptor agonist
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
LIT-001
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
NP-1031
Enzyme that metabolizes substances by oxidation
amiodarone (class III antiarrhythmic), aprepitant, (antiemetic) ciprofloxacin, conivaptan, crizotinib, rutin (in vitro) (dietary flavonoid), tofisopam, some calcium
CYP3A4
Substance that promotes the production of urine
Selective vasopressin V2 antagonist (sometimes called aquaretics) tolvaptan, conivaptan Competitive vasopressin antagonism leads to decreased number of aquaporin
Diuretic
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Atosiban
Medication causing uterine contraction
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Uterotonic
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Cligosiban
Peptide hormone and neuropeptide
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Oxytocin
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
SRX251
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Terlipressin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
SRX246
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
WAY-267464
Medication used to treat insomnia
suvorexant include the strong CYP3A4 inhibitors boceprevir, clarithromycin, conivaptan, indinavir, itraconazole, ketoconazole, lopinavir, nefazodone, nelfinavir
Suvorexant
Medication used to treat insomnia
daridorexant include the strong CYP3A4 inhibitors boceprevir, clarithromycin, conivaptan, indinavir, itraconazole, ketoconazole, lopinavir, nefazodone, nelfinavir
Daridorexant
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Brezivaptan
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Balovaptan
Medication made from the peptide oxytocin
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Oxytocin_(medication)
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
KNX-100
Protein-coding gene in the species Homo sapiens
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasopressin_receptor_1B
Medication used for preventing postpartum bleeding
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Carbetocin
Carrier protein for oxytocin and vasopressin
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Neurophysins
Medical condition
sympatholytic beta blocker Vasopressin receptor antagonists, such as conivaptan Acetazolamide, a carbonic anhydrase inhibitor Lithium was previously used
Primary_polydipsia
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasopressin_(medication)
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Nelivaptan
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
KNX-101
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Barusiban
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Ornipressin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Demeclocycline
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
NTX-1472
Cleavage product of the arginine vasopressin gene
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Neurophysin_II
Cleavage product of the coding protein of OXT gene
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Neurophysin_I
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
CA7_(drug)
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
L-371,257
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Lixivaptan
Combination drug
avoided when prescribing. Moderate CYP3A4 inhibitors such as berotralstat, conivaptan, crizotinib, diltiazem, dronedarone, duvelisib, fedratinib, fluconazole
Bellergal
G protein-coupled receptor
receptor antagonists include the new class of "vaptan drugs" such as conivaptan, tolvaptan, mozavaptan, lixivaptan, satavaptan etc. Holmes CL, Landry
Vasopressin_receptor
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasotocin
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
WJ0679
(INN) Conexxence Congess Jr. Congess Sr. Congest Congestac Congestant D conivaptan (INN) conorfone (INN) Conray Constant-T Tablet Constilac Constulose Contac
List_of_drugs:_Cm–Co
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
PF-06655075
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Nolasiban
Pharmaceutical drug classification
C03EB03 Torasemide and potassium-sparing agents C03XA01 Tolvaptan C03XA02 Conivaptan "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"
ATC_code_C03
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
ABT-436
All-time high healthcare and patient drug shortage
manufacturing practices", increased demand, estimated recovery Oct-Dec. 2024 Conivaptan HCl Cardiovascular Shipping delay Cromolyn Sodium Respiratory Increased
2024 United States drug shortages
2024_United_States_drug_shortages
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Felypressin
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
PF-184563
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Merotocin
Oxytocin receptor antagonist
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Tocinoic_acid
Vasopressin V1A receptor antagonist
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
RG7713
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
NMRA-511
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Lipo-oxytocin-1
Genes on human chromosome 3
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Oxytocin_receptor
Chemical compound
saquinavir, nelfinavir, indinavir, boceprevir, telaprevir, telithromycin, and conivaptan. CYP3A4 inducers, such as carbamazepine, rifampin, St. John's wort, and
Vorapaxar
Protein-coding gene in the species Homo sapiens
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasopressin_receptor_1A
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Satavaptan
Chemical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Epelsiban
Medical treatment for cerebral edema
formation of cerebral edema. This can be prevented by administration of conivaptan, a safe FDA approved drug that treats euvolemic hyponatremia. Through
Osmotherapy
dysfunctional or non-functional and thereby ineffective. Tolvaptan and conivaptan antagonize the effects of antidiuretic hormone (vasopressin), thereby
Management_of_heart_failure
Protein-coding gene in the species Homo sapiens
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
Vasopressin_receptor_2
Pharmaceutical compound
(argipressin) Vasotocin (argiprestocin) Antagonists: Atosiban Balovaptan Conivaptan FR-218944 JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472
OT-12
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN
CONIVAPTAN